Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 146 peer-reviewed journal articles Updated
Neurology · Developmental and Epileptic Encephalopathy

Understanding Your Child's DEE Diagnosis

At a Glance

Developmental and Epileptic Encephalopathy (DEE) is a group of severe, early-onset epilepsies that affect brain development and cause frequent seizures. Early genetic testing is essential because it allows doctors to use precision medicine therapies tailored to a child's specific mutation.

Receiving a diagnosis of Developmental and Epileptic Encephalopathy (DEE) for your child is a life-altering moment that can feel overwhelming and isolating. These are rare conditions, and it is common for local pediatricians or general neurologists to have limited experience with them because DEEs are complex and require highly specialized care [1][2].

Defining DEE in Plain Language

A Developmental and Epileptic Encephalopathy (DEE) is a group of severe, early-onset epilepsies where two things happen at once:

  1. Developmental Encephalopathy (DE): The underlying genetic cause itself affects how the brain develops and functions, regardless of seizure activity [1][3].
  2. Epileptic Encephalopathy (EE): Frequent, intense electrical activity in the brain (seizures and abnormal EEG patterns) further disrupts brain function and can cause a child to lose skills they once had, a process known as regression [4][5].

DEE is heterogeneous, meaning it varies significantly from one child to another [6]. Even two children with the same genetic mutation may have different seizure types or developmental paths [7][8].

To navigate this journey, we have created a comprehensive guide. Here is what you will find in the following pages:

01

The Science of DEE: Why Your Child's Mutation Matters

Learn how genetic mutations in Developmental and Epileptic Encephalopathy (DEE) impact your child's brain. Understand GoF vs LoF and precision medicine.

02

Reading the Roadmap: Decoding Your Child's Reports

Learn how to decode your child's DEE genetic and EEG reports. Understand terms like pathogenic, de novo, hypsarrhythmia, and what they mean for care.

03

Beyond the Seizures: Symptoms and Development in DEE

Learn about Developmental and Epileptic Encephalopathy (DEE) symptoms beyond seizures. Understand developmental delays, GI issues, sleep, and CVI in children.

04

Targeted Hope: Treatment and Precision Medicine

Learn about precision medicine for Developmental and Epileptic Encephalopathy (DEE). Understand targeted treatments for SCN1A, CDKL5, and the ketogenic diet.

05

Building Your Team and Staying Safe

Learn how to build a multidisciplinary care team for Developmental and Epileptic Encephalopathy (DEE). Understand SUDEP risks, safety strategies, and more.

06

The Long-Term Journey: Quality of Life and Transition

Learn about the long-term journey of genetic Developmental and Epileptic Encephalopathy (DEE). Understand adult care transition, palliative support, and QoL.

Stabilizing Facts for Families

When the world feels like it is spinning, these three facts can help ground your family’s perspective:

  • The diagnosis is the first step toward precision: Identifying the specific genetic cause allows doctors to move away from “trial and error” and toward precision medicine—using treatments tailored to your child’s specific gene [9][10].
  • Early intervention is the standard of care: Starting genetic testing and specialized therapies as early as possible is the globally recognized way to give your child the best possible developmental opportunity [11][12].
  • You are part of a specialized community: While rare, there are dedicated researchers and parent-led organizations for almost every known DEE gene (such as STXBP1, SCN2A, or KCNQ2) [7][8].

Typical First Symptoms

DEE usually appears in the first months of life [13][14]. The first signs often include:

  • Refractory seizures: Seizures that do not respond to the first or second common anti-seizure medications [10][14].
  • Specific seizure types: This may include infantile spasms (sudden stiffening or “jackknife” movements) or focal seizures [15][16].
  • Developmental stagnation: A child may stop hitting milestones like rolling over, making eye contact, or babbling [13][17].
  • Non-seizure movements: Some children show severe tremors, unusual startle responses, or very low muscle tone (hypotonia) [18][19].

Why Genetic Testing is Essential

In the past, these conditions were diagnosed based only on seizure types. Today, early genetic testing (like Whole Exome Sequencing) is the “gold standard” for several reasons:

  • Targeted Treatment: Some medications that help one child could actually make seizures worse for another child with a different mutation [10][20].
  • Prognosis: Knowing the gene helps doctors understand what to expect regarding future development and health needs [9][21].
  • Family Planning: Testing provides critical information for families who may want to have more children [22][23].

Knowns and Unknowns

What Research Agrees On What Remains Uncertain
Early genetic diagnosis significantly improves the chance of finding the right treatment [9][24]. Why two children with the same mutation can have vastly different outcomes [6].
Aggressive treatment of seizures can sometimes “unlock” developmental progress [3]. How to fully prevent the developmental impact caused by the gene itself (the “DE” part) [3].
DEE requires a multi-specialty team (neurology, genetics, therapies) [12]. The long-term impact and “natural history” of many newly discovered rare genetic variants [25].

Research is currently shifting toward Antisense Oligonucleotides (ASOs) and gene therapies, which aim to “fix” or compensate for the genetic error rather than just treating the symptoms [26][20].

Common questions in this guide

What is the difference between developmental and epileptic encephalopathy?
Developmental encephalopathy means the genetic mutation itself affects brain development. Epileptic encephalopathy occurs when frequent seizures further disrupt brain function, often causing a child to lose previously gained skills.
Why is genetic testing important for a child with DEE?
Early genetic testing is crucial because it helps identify the exact underlying cause of the condition. Knowing the specific gene mutation allows doctors to use precision medicine, choosing treatments most likely to help while avoiding medications that could worsen seizures.
What are the typical first symptoms of DEE?
Early signs usually appear in the first months of life and include seizures that do not respond to standard medications. Other common symptoms are infantile spasms, delays in reaching milestones, and unusually low muscle tone.
What does it mean if my child's development stagnates or regresses?
Developmental stagnation means a child stops hitting milestones like rolling over or making eye contact. Regression happens when intense electrical activity in the brain from seizures causes a child to actively lose skills they previously had.
How does precision medicine help treat DEE?
Precision medicine uses treatments tailored to your child's specific genetic mutation rather than a trial-and-error approach. By targeting the underlying cause of the seizures, these specialized therapies can sometimes improve seizure control and support developmental progress.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my child's specific genetic variant suggest a gain-of-function or loss-of-function mutation, and how does that change our choice of medication?
  2. 2.Is the developmental delay we are seeing mostly 'developmental' (from the gene itself) or 'epileptic' (caused by the seizure activity)?
  3. 3.What specific EEG patterns, such as hypsarrhythmia or suppression-burst, have you identified in my child's testing?
  4. 4.Are there precision therapies or clinical trials available for this specific genetic mutation?
  5. 5.Does our current care team include all the necessary specialists for non-seizure symptoms, like physical therapists or feeding specialists?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (26)
  1. 1

    Developmental and epileptic encephalopathies: what we do and do not know.

    Specchio N, Curatolo P

    Brain : a journal of neurology 2021; (144(1)):32-43 doi:10.1093/brain/awaa371.

    PMID: 33279965
  2. 2

    Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy.

    Wang W, Frankel WN

    Neurobiology of disease 2021; (148()):105220 doi:10.1016/j.nbd.2020.105220.

    PMID: 33301879
  3. 3

    Developmental and epileptic encephalopathies: recognition and approaches to care.

    Raga S, Specchio N, Rheims S, Wilmshurst JM

    Epileptic disorders : international epilepsy journal with videotape 2021; (23(1)):40-52 doi:10.1684/epd.2021.1244.

    PMID: 33632673
  4. 4

    Developmental and epileptic encephalopathy with spike-wave activation in sleep: From the 'functional ablation' model to a neurodevelopmental network perspective.

    Andreoli L, Bova SM, Veggiotti P

    Developmental medicine and child neurology 2025; (67(10)):1250-1256 doi:10.1111/dmcn.16361.

    PMID: 40356337
  5. 5

    Anatomo-Electro-Clinical Phenotypes in Children With Epilepsy and DYNC1H1 Mutations.

    Gutiérrez-Delicado E, García-Fernández M, Ortiz Cabrera NV, et al.

    Pediatric neurology 2025; (163()):7-11 doi:10.1016/j.pediatrneurol.2024.11.003.

    PMID: 39631264
  6. 6

    Early infantile epileptic encephalopathy related to NECAP1: Clinical delineation of the disease and review.

    Chouery E, Mehawej C, Sabbagh S, et al.

    European journal of neurology 2022; (29(8)):2486-2492 doi:10.1111/ene.15424.

    PMID: 35638367
  7. 7

    Genetic Etiology of Developmental and Epileptic Encephalopathy in a Turkish Cohort: A Single-Center Study with Targeted Gene Panel and Whole Exome Sequencing.

    Sunnetci-Akkoyunlu D, Kara B, Ozer T, et al.

    Genes 2025; (16(10)) doi:10.3390/genes16101152.

    PMID: 41153369
  8. 8

    Developmental epileptic encephalopathy caused by homozygosity of a c.172+1G>C variant in the WWOX gene.

    You Y, Wu W, Du Y, et al.

    Molecular genetics & genomic medicine 2024; (12(8)):e2500 doi:10.1002/mgg3.2500.

    PMID: 39101447
  9. 9

    Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.

    Na JH, Shin S, Yang D, et al.

    Brain & development 2020; (42(6)):438-448 doi:10.1016/j.braindev.2020.02.004.

    PMID: 32139178
  10. 10

    Genetic and clinical features of SCN8A developmental and epileptic encephalopathy.

    Kim HJ, Yang D, Kim SH, et al.

    Epilepsy research 2019; (158()):106222 doi:10.1016/j.eplepsyres.2019.106222.

    PMID: 31675620
  11. 11

    Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

    Sturm AC, Knowles JW, Gidding SS, et al.

    Journal of the American College of Cardiology 2018; (72(6)):662-680 doi:10.1016/j.jacc.2018.05.044.

    PMID: 30071997
  12. 12

    Genetic evaluation of children with autism spectrum disorders in developing and low-resource areas.

    Masri AT, Nasir A, Irshaid F, et al.

    Autism : the international journal of research and practice 2022; (26(6)):1491-1498 doi:10.1177/13623613211055535.

    PMID: 34781785
  13. 13

    CDKL5 Deficiency Disorder-A Complex Epileptic Encephalopathy.

    Jakimiec M, Paprocka J, Śmigiel R

    Brain sciences 2020; (10(2)) doi:10.3390/brainsci10020107.

    PMID: 32079229
  14. 14

    CDKL5-associated developmental and epileptic encephalopathy: A long-term, longitudinal electroclinical study of 22 cases.

    Darra F, Monchelato M, Loos M, et al.

    Epilepsy research 2023; (190()):107098 doi:10.1016/j.eplepsyres.2023.107098.

    PMID: 36739728
  15. 15

    The Expanding Clinical Spectrum of Genetic Pediatric Epileptic Encephalopathies.

    Shbarou R, Mikati MA

    Seminars in pediatric neurology 2016; (23(2)):134-42.

    PMID: 27544470
  16. 16

    Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long-read sequencing.

    Mehinovic E, Gray T, Campbell M, et al.

    American journal of medical genetics. Part A 2022; (188(7)):2071-2081 doi:10.1002/ajmg.a.62743.

    PMID: 35366058
  17. 17

    Early onset developmental and epileptic encephalopathy and Rett-like phenotype in a 15-year-old girl affected by Cornelia de Lange syndrome type 2 due to a SMC1A gene mutation.

    Parmeggiani L, Stanzial F, Menna E, et al.

    Epilepsy & behavior reports 2023; (24()):100634 doi:10.1016/j.ebr.2023.100634.

    PMID: 38076278
  18. 18

    Neonatal tremor episodes and hyperekplexia-like presentation at onset in a child with SCN8A developmental and epileptic encephalopathy.

    Pons L, Lesca G, Sanlaville D, et al.

    Epileptic disorders : international epilepsy journal with videotape 2018; (20(4)):289-294 doi:10.1684/epd.2018.0988.

    PMID: 30078772
  19. 19

    Novel homozygous AP3B2 mutations in four individuals with developmental and epileptic encephalopathy: A rare clinical entity.

    Dilber C, Yücel G, Şahin Y

    Clinical neurology and neurosurgery 2022; (223()):107509 doi:10.1016/j.clineuro.2022.107509.

    PMID: 36356440
  20. 20

    PGAP2-Related Hyperphosphatasia-Mental Retardation Syndrome: Report of a Novel Patient, Toward a Broadening of Phenotypic Spectrum and Therapeutic Perspectives.

    Saracino A, Totaro M, Politano D, et al.

    Neuropediatrics 2024; (55(2)):129-134 doi:10.1055/s-0044-1779613.

    PMID: 38365198
  21. 21

    Predictors of genetic diagnosis in individuals with developmental and epileptic encephalopathies.

    Luiza Benevides M, de Moraes HT, Granados DMM, et al.

    Epilepsy & behavior : E&B 2024; (155()):109762 doi:10.1016/j.yebeh.2024.109762.

    PMID: 38636144
  22. 22

    The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway.

    Leren TP, Bogsrud MP

    Journal of clinical lipidology 2021; (15(5)):674-681 doi:10.1016/j.jacl.2021.08.007.

    PMID: 34479846
  23. 23

    Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.

    Alejandra Restrepo-Cordoba M, Campuzano O, Ripoll-Vera T, et al.

    Journal of cardiovascular translational research 2017; (10(1)):35-46 doi:10.1007/s12265-017-9730-8.

    PMID: 28138913
  24. 24

    Genetic analysis using targeted exome sequencing of 53 Vietnamese children with developmental and epileptic encephalopathies.

    Hieu NLT, Thu NTM, Ngan LTA, et al.

    American journal of medical genetics. Part A 2022; (188(7)):2048-2060 doi:10.1002/ajmg.a.62741.

    PMID: 35365919
  25. 25

    Caregiver-reported meaningful change in functional domains for individuals with developmental and epileptic encephalopathy: A convergent mixed-methods design.

    Downs J, Haywood S, Ludwig NN, et al.

    Developmental medicine and child neurology 2025; (67(12)):1616-1627 doi:10.1111/dmcn.16363.

    PMID: 40372822
  26. 26

    Comprehensive genetic diagnosis and therapeutic perspectives in 155 children with developmental and epileptic encephalopathy.

    van Heurck R, Hammar EB, Ville D, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (56()):97-103 doi:10.1016/j.ejpn.2025.04.014.

    PMID: 40347601

This page provides a general overview of DEE diagnosis for educational purposes. Always consult your child's pediatric neurologist and geneticist for specific medical advice, genetic test interpretation, and treatment planning.

Get notified when new evidence is published on Genetic developmental and epileptic encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.